Your browser is no longer supported. Please, upgrade your browser.
ACHV Achieve Life Sciences, Inc. monthly Stock Chart
ACHV [NASD]
Achieve Life Sciences, Inc.
Index- P/E- EPS (ttm)-8.76 Insider Own0.49% Shs Outstand3.59M Perf Week1.11%
Market Cap32.67M Forward P/E- EPS next Y-5.30 Insider Trans0.00% Shs Float3.42M Perf Month11.25%
Income-13.20M PEG- EPS next Q-1.28 Inst Own14.90% Short Float16.66% Perf Quarter11.66%
Sales- P/S- EPS this Y45.00% Inst Trans0.38% Short Ratio2.78 Perf Half Y9.80%
Book/sh7.81 P/B1.17 EPS next Y9.40% ROA-64.50% Target Price- Perf Year-50.62%
Cash/sh- P/C- EPS next 5Y- ROE-72.10% 52W Range4.51 - 28.00 Perf YTD-14.13%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-67.50% Beta1.89
Dividend %- Quick Ratio13.00 Sales past 5Y- Gross Margin- 52W Low101.56% ATR0.73
Employees14 Current Ratio13.00 Sales Q/Q- Oper. Margin- RSI (14)52.94 Volatility6.68% 9.05%
OptionableNo Debt/Eq0.00 EPS Q/Q87.40% Profit Margin- Rel Volume0.32 Prev Close9.07
ShortableYes LT Debt/Eq0.00 EarningsNov 12 AMC Payout- Avg Volume204.82K Price9.10
Recom1.70 SMA203.40% SMA502.15% SMA2006.34% Volume65,523 Change0.33%
Nov-24-20 11:26AM  
Nov-16-20 05:16AM  
Nov-12-20 04:05PM  
04:05PM  
02:30PM  
Oct-29-20 05:30AM  
Oct-27-20 05:30AM  
Oct-08-20 06:30AM  
Oct-07-20 06:30AM  
Sep-30-20 08:00AM  
08:00AM  
Sep-21-20 06:17AM  
Sep-18-20 09:30AM  
07:00AM  
Sep-10-20 05:30AM  
Sep-03-20 05:30AM  
Aug-24-20 11:10AM  
Aug-06-20 04:05PM  
Jun-30-20 09:33AM  
Jun-29-20 08:35AM  
08:35AM  
08:30AM  
08:30AM  
Jun-05-20 02:49PM  
May-29-20 05:54AM  
May-14-20 07:30AM  
May-05-20 08:00AM  
Apr-30-20 04:50PM  
Apr-06-20 05:40AM  
Apr-02-20 08:00AM  
Mar-13-20 08:00AM  
08:00AM  
Mar-12-20 05:30AM  
Mar-03-20 05:30AM  
Feb-06-20 08:00AM  
Jan-13-20 06:30AM  
Dec-23-19 05:31AM  
Dec-19-19 04:05PM  
04:05PM  
Dec-17-19 01:06PM  
01:06PM  
Dec-09-19 05:30AM  
05:30AM  
Nov-11-19 10:00AM  
Nov-06-19 06:30AM  
06:30AM  
Oct-31-19 05:30AM  
Oct-24-19 07:11AM  
05:30AM  
05:30AM  
Sep-30-19 05:30AM  
Sep-25-19 06:30AM  
Sep-13-19 05:30AM  
Sep-09-19 10:34AM  
Sep-05-19 05:30AM  
Sep-04-19 05:30AM  
Aug-26-19 02:30PM  
10:30AM  
Aug-08-19 05:39PM  
04:05PM  
Jul-30-19 05:30AM  
05:30AM  
Jul-23-19 05:30AM  
Jul-10-19 10:47AM  
Jun-21-19 10:38AM  
05:30AM  
Jun-12-19 01:00PM  
Jun-11-19 07:00AM  
07:00AM  
Jun-03-19 04:05PM  
04:05PM  
May-30-19 02:00PM  
05:30AM  
May-15-19 04:05PM  
04:05PM  
May-07-19 05:30AM  
Apr-26-19 10:00AM  
Apr-24-19 05:30AM  
Apr-03-19 05:30AM  
Apr-02-19 07:30AM  
05:30AM  
Mar-25-19 10:00AM  
Mar-18-19 08:35AM  
05:30AM  
Mar-15-19 04:05PM  
Mar-14-19 04:05PM  
Mar-12-19 01:00PM  
Mar-05-19 05:30AM  
Feb-28-19 09:00AM  
Feb-25-19 10:30AM  
06:26AM  
Feb-22-19 10:40AM  
08:36AM  
05:30AM  
Feb-20-19 05:30AM  
Dec-28-18 07:06AM  
Dec-18-18 05:30AM  
Nov-29-18 08:06AM  
Nov-28-18 07:04AM  
Nov-07-18 04:05PM  
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bencich JohnCFO & COOAug 18Option Exercise0.00690174Aug 19 04:26 PM
JACOBS CINDYEVP, CMOAug 18Option Exercise0.00690209Aug 19 04:25 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.